Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your Favorites.
This session is in your Favorites. Click again to remove it.
Presentation Icons
ACG Award Winner
ACG Newsworthy Abstract
Registration Required
No CME
On-Demand Video
Livestream
Back
Favorite
Email
Post (Tweet)
Abigail M. Wojtowicz, PhD
Takeda
Poster(s):
P0917 - Low Rates of Transition From Subcutaneous to Intravenous Formulation in Patients With Inflammatory Bowel Diseases Treated With Vedolizumab
Sunday, October 27, 2024
3:30 PM – 7:00 PM
ET
P0918 - Comparative Efficacy and Safety of Subcutaneous Vedolizumab versus Other Targeted Inflammatory Bowel Disease Therapies in Patients With Moderate to Severe Ulcerative Colitis: A Network Meta-Analysis
Sunday, October 27, 2024
3:30 PM – 7:00 PM
ET
Email Abigail